Enjoy complimentary customisation on priority with our Enterprise License!
The degenerative disc disease market share is expected to increase by USD 1.03 billion from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 8.51%.
This degenerative disc disease market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers degenerative disc disease market segmentations by product (drugs and devices) and geography (North America, Europe, Asia, and Rest of World (ROW)). The degenerative disc disease (DDD) market report also offers information on several market vendors, including AnGes Inc., Ankasa, B. Braun SE, BIOPHARM GmbH, BioRestorative Therapies Inc., Biosplice Therapeutics Inc., Bone Therapeutics SA, CalSpine MD, Cousin Biotech, DiscGenics Inc., Globus Medical Inc., Johnson and Johnson, Medtronic Plc, Pfizer Inc., RTI Surgical Inc., Smith and Nephew plc, Ulrich Medical USA Inc., and Zimmer Biomet Holdings Inc. among others.
Download Report Sample to Unlock the Degenerative Disc Disease Market Size for the Forecast Period and Other Important Statistics
The growing geriatric population is notably driving the degenerative disc disease market growth, although factors such as the availability of alternative therapies may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the degenerative disc disease industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Degenerative Disc Disease Market Driver
The growing geriatric population is one of the key drivers fueling the degenerative disc disease market growth. Primarily, human intervertebral discs undergo age-related degenerative changes that contribute to some of the most common causes of impairment and disability in the older population, such as spine stiffness, neck pain, and back pain. The spine is made up of bones and intervertebral discs. With age, the discs become dry and lose their protection of the bones. Thus, the aging population is more prone to DDD, and the growing aging population globally will thus spur the demand for DDD treatment during the forecast period.
Key Degenerative Disc Disease Market Trend
The launch of innovative products is one of the key DDD market trends propelling market growth. The technologically advanced products are more effective in the treatment of DDD compared to the available treatments. For instance, in May 2020, DePuy Synthes announced the launch of their new technology, the CONCORDE LIFT Interbody Implant. The new implantable device was designed to help treat patients suffering from DDD. This implant has been specially designed to help simplify important stages of spinal fusion surgery to help restore spinal disc height between two vertebrae. Thus, the launch of such innovative and technologically advanced products will boost the growth of the market during the forecast period.
Key Degenerative Disc Disease Market Challenge
The availability of alternative therapies is one of the factors hindering the degenerative disc disease market growth. Nowadays, with rising awareness about the side effects of medications, the majority of the population is moving toward exercise and physiotherapy. It relieves pain and increases movement and flexibility through exercise therapy, manual therapy to improve joint flexibility and muscle stiffness, posture and movement education, and pain-relieving treatments such as traction and electrical stimulation. Such physiotherapist-directed exercise therapy, healthy eating, and aerobic exercise also help to reduce body weight and, therefore, spinal load. Thus, the rising popularity of physiotherapies and other exercises for the treatment of DDD will impede the growth of the market during the forecast period.
This degenerative disc disease market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global degenerative disc disease (DDD) market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the degenerative disc disease market during the forecast period.
The report analyzes the market’s competitive landscape and offers information on several market vendors, including:
This statistical study of the degenerative disc disease market encompasses successful business strategies deployed by the key vendors. The degenerative disc disease market is fragmented and the vendors are deploying growth strategies such as pricing, R&D, quality, geographical coverage, product offerings, and the development of technologically advanced products to compete in the market.
To make the most of the opportunities and recover from the post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The degenerative disc disease market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the degenerative disc disease market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
For more insights on the market share of various regions Request PDF Sample now!
42% of the market’s growth will originate from North America during the forecast period. The US is the key market for the degenerative disc disease market in North America. Market growth in this region will be slower than the growth of the market in Asia.
The rising geriatric population will facilitate the degenerative disc disease market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
The regional market growth declined in 2020 due to the outbreak of COVID-29. However, large-scale vaccination drives, the adoption of telehealth, and the lifting of stay-at-home policies regained market revenue in the region in the first half of 2021. In addition, returning to normalcy and fastened research programs for DDD treatment are expected to drive the growth of the market during the forecast period.
To gain further insights on the market contribution of various segments Request PDF Sample
The degenerative disc disease (DDD) market share growth by the drugs segment will be significant during the forecast period. The segment is expected to grow during the forecast period owing to the rising incidence of DDD among the geriatric population. Spinal disc degeneration is a normal part of aging. Between 70% and 80% of people under the age of 50 and over 90% of people over the age of 60 have degenerative disc disease. Moreover, DDD is initially treated conservatively with over-the-counter or prescription drugs and nonsteroidal anti-inflammatory drugs (NSAIDs).
This report provides an accurate prediction of the contribution of all the segments to the growth of the degenerative disc disease market size and actionable market insights on the post-COVID-19 impact on each segment.
Degenerative Disc Disease Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 8.51% |
Market growth 2022-2026 |
$ 1.03 billion |
Market structure |
Fragmented |
YoY growth (%) |
8.0 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 42% |
Key consumer countries |
US, Germany, UK, China, and Japan |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
AnGes Inc., Ankasa, B. Braun SE, BIOPHARM GmbH, BioRestorative Therapies Inc., Biosplice Therapeutics Inc., Bone Therapeutics SA, CalSpine MD, Cousin Biotech, DiscGenics Inc., Globus Medical Inc., Johnson and Johnson, Medtronic Plc, Pfizer Inc., RTI Surgical Inc., Smith and Nephew plc, Ulrich Medical USA Inc., and Zimmer Biomet Holdings Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Product
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.